Jiangxi Fushine Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 340.43 million compared to CNY 397.92 million a year ago. Revenue was CNY 340.43 million compared to CNY 397.92 million a year ago.

Net income was CNY 1.47 million compared to net loss of CNY 30.15 million a year ago. Basic earnings per share from continuing operations was CNY 0.003 compared to basic loss per share from continuing operations of CNY 0.056 a year ago. Diluted earnings per share from continuing operations was CNY 0.003 compared to diluted loss per share from continuing operations of CNY 0.056 a year ago.